777
Views
16
CrossRef citations to date
0
Altmetric
Review Article

Nitric oxide in the human uterine cervix: Endogenous ripening factor

, MD PhD
Pages 45-55 | Published online: 08 Jul 2009

References

  • Maul H., Longo M., Saade G. R., Garfield R. E. Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr Pharm Des 2003; 9: 359–80
  • Leppert P. C. Anatomy and physiology of cervical ripening. Clin Obstet Gynecol 1995; 38: 267–79
  • Maul H., Mackay L., Garfield R. E. Cervical ripening: biochemical, molecular, and clinical considerations. Clin Obstet Gynecol 2006; 49: 551–63
  • Word R. A., Li X. H., Hnat M., Carrick K. Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. Semin Reprod Med 2007; 25: 69–79
  • Ludmir J., Sehdev H. M. Anatomy and physiology of the uterine cervix. Clin Obstet Gynecol 2000; 43: 433–39
  • Junqueira L. C., Zugaib M., Montes G. S., Toledo O. M., Krisztan R. M., Shigihara K. M. Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation. Am J Obstet Gynecol 1980; 138: 273–81
  • Liggins G. C. Cervical ripening as an inflammatory reaction. The cervix in pregnancy and labour. Clinical and biochemical investigation, D. A Ellwood, A. M. B Anderson. Churchill Livingstone, Edinburgh 1981; 1–9
  • Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L‐arginine. Nature 1988; 333: 664–6
  • Palmer R. M., Moncada S. A novel citrulline‐forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 1989; 158: 348–52
  • Marletta M. A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994; 78: 927–30
  • Pollock J. S., Forstermann U., Mitchell J. A., Warner T. D., Schmidt H. H., Nakane M., et al. Purification and characterization of particulate endothelium‐derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A 1991; 88: 10480–4
  • Xie Q. W., Cho H. J., Calaycay J., Mumford R. A., Swiderek K. M., Lee T. D., et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225–8
  • Nakane M., Schmidt H. H., Pollock J. S., Forstermann U., Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993; 316: 175–80
  • Knowles R. G., Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249–58
  • Radomski M. W., Palmer R. M., Moncada S. Characterization of the L‐arginine: nitric oxide pathway in human platelets. Br J Pharmacol 1990; 101: 325–8
  • Moilanen E., Moilanen T., Knowles R., Charles I., Kadoya Y., al‐Saffar N., et al. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol 1997; 150: 881–7
  • Murad F. Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci Rep 1999; 19: 133–54
  • Hogg N. The biochemistry and physiology of S‐nitrosothiols. Annu Rev Pharmacol Toxicol 2002; 42: 585–600
  • Farrell A. J., Blake D. R. Nitric oxide. Ann Rheum Dis 1996; 55: 7–20
  • Tschugguel W., Schneeberger C., Lass H., Stonek F., Zaghlula M. B., Czerwenka K., et al. Human cervical ripening is associated with an increase in cervical inducible nitric oxide synthase expression. Biol Reprod 1999; 60: 1367–72
  • Ledingham M. A., Thomson A. J., Young A., Macara L. M., Greer I. A., Norman J. E. Changes in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturition. Mol Hum Reprod 2000; 6: 1041–8
  • Bao S., Rai J., Schreiber J. Brain nitric oxide synthase expression is enhanced in the human cervix in labor. J Soc Gynecol Investig 2001; 8: 158–64
  • Chwalisz K., Shao‐Qing S., Garfield R. E., Beier H. M. Cervical ripening in guinea‐pigs after a local application of nitric oxide. Hum Reprod 1997; 12: 2093–101
  • Buhimschi I., Ali M., Jain V., Chwalisz K., Garfield R. E. Differential regulation of nitric oxide in the rat uterus and cervix during pregnancy and labour. Hum Reprod 1996; 11: 1755–66
  • Aalberts M., van Dissel‐Emiliani F. M., van Tol H. T., Taverne M. A., Breeveld‐Dwarkasing V. N. High iNOS mRNA and protein levels during early third trimester suggest a role for NO in prelabor cervical ripening in the bovine. Mol Reprod Dev 2007; 74: 378–85
  • Leppert P. C., Kokenyesi R., Klemenich C. A., Fisher J. Further evidence of a decorin‐collagen interaction in the disruption of cervical collagen fibers during rat gestation. Am J Obstet Gynecol 2000; 182: 805–11
  • Ekerhovd E., Brannstrom M., Weijdegard B., Norstrom A. Nitric oxide synthases in the human cervix at term pregnancy and effects of nitric oxide on cervical smooth muscle contractility. Am J Obstet Gynecol 2000; 183: 610–6
  • Brune B., von Knethen A., Sandau K. B. Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998; 351: 261–72
  • Ekerhovd E., Weijdegard B., Brannstrom M., Mattsby‐Baltzer I., Norstrom A. Nitric oxide induced cervical ripening in the human: Involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2). Am J Obstet Gynecol 2002; 186: 745–50
  • Ledingham M. A., Denison F. C., Riley S. C., Norman J. E. Matrix metalloproteinases‐2 and ‐9 and their inhibitors are produced by the human uterine cervix but their secretion is not regulated by nitric oxide donors. Hum Reprod 1999; 14: 2089–96
  • Vaisanen‐Tommiska M., Butzow R., Ylikorkala O., Mikkola T. S. Mifepristone‐induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy. Hum Reprod 2006; 21: 2180–4
  • Thomson A. J., Telfer J. F., Kohnen G., Young A., Cameron I. T., Greer I. A., et al. Nitric oxide synthase activity and localization do not change in uterus and placenta during human parturition. Hum Reprod 1997; 12: 2546–52
  • Vaisanen‐Tommiska M., Nuutila M., Aittomaki K., Hiilesmaa V., Ylikorkala O. Nitric oxide metabolites in cervical fluid during pregnancy: further evidence for the role of cervical nitric oxide in cervical ripening. Am J Obstet Gynecol 2003; 188: 779–85
  • Ali M., Buhimschi I., Chwalisz K., Garfield R. E. Changes in expression of the nitric oxide synthase isoforms in rat uterus and cervix during pregnancy and parturition. Mol Hum Reprod 1997; 3: 995–1003
  • Garfield R. E., Saade G., Buhimschi C., Buhimschi I., Shi L., Shi S. Q., et al. Control and assessment of the uterus and cervix during pregnancy and labour. Hum Reprod Update 1998; 4: 673–95
  • Chwalisz K., Garfield R. E. Role of nitric oxide in the uterus and cervix: implications for the management of labor. J Perinat Med 1998; 26: 448–57
  • Chiossi G., Verocchi G., Venturini P., Facchinetti F. Changes in cervical nitric oxide concentration correlate with Bishop score and cervical length modifications in prostaglandin e2‐mediated induction of labor. J Soc Gynecol Investig 2006; 13: 203–8
  • Huber A., Hudelist G., Czerwenka K., Husslein P., Kubista E., Singer C. F. Gene expression profiling of cervical tissue during physiological cervical effacement. Obstet Gynecol 2005; 105: 91–8
  • Nakatsuka M., Habara T., Kamada Y., Tada K., Kudo T. Elevation of total nitrite and nitrate concentration in vaginal secretions as a predictor of premature delivery. Am J Obstet Gynecol 2000; 182: 644–5
  • Facchinetti F., Venturini P., Blasi I., Giannella L. Changes in the cervical competence in preterm labour. BJOG 2005; 112 Suppl 1: 23–7
  • Yoshida M., Sagawa N., Itoh H., Yura S., Korita D., Kakui K., et al. Nitric oxide increases matrix metalloproteinase‐1 production in human uterine cervical fibroblast cells. Mol Hum Reprod 2001; 7: 979–85
  • Biondi C., Pavan B., Lunghi L., Fiorini S., Vesce F. The role and modulation of the oxidative balance in pregnancy. Curr Pharm Des 2005; 11: 2075–89
  • Leppert P. C. Proliferation and apoptosis of fibroblasts and smooth muscle cells in rat uterine cervix throughout gestation and the effect of the antiprogesterone onapristone. Am J Obstet Gynecol 1998; 178: 713–25
  • Vaisanen‐Tommiska M., Mikkola T. S., Ylikorkala O. Increased release of cervical nitric oxide in spontaneous abortion before clinical symptoms: a possible mechanism for preabortal cervical ripening. J Clin Endocrinol Metab 2004; 89: 5622–6
  • Marinoni E., Di Iorio R., Lucchini C., Di Netta T., Letizia C., Cosmi E. V. Adrenomedullin and nitric oxide synthase at the maternal‐decidual interface in early spontaneous abortion. J Reprod Med 2004; 49: 153–61
  • Haddad E. K., Duclos A. J., Baines M. G. Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. J Exp Med 1995; 182: 1143–51
  • Ogando D. G., Paz D., Cella M., Franchi A. M. The fundamental role of increased production of nitric oxide in lipopolysaccharide‐induced embryonic resorption in mice. Reproduction 2003; 125: 95–110
  • Reis F. M., Faletti A., Luisi S., Bifulco G., Cauci S., Quadrifoglio F., et al. High concentrations of inhibin A and inhibin B in ovarian serous cystadenoma: relationship with oestradiol and nitric oxide metabolites. Mol Hum Reprod 2000; 6: 1079–83
  • Muttukrishna S., Jauniaux E., Greenwold N., McGarrigle H., Jivraj S., Carter S., et al. Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod 2002; 17: 3072–8
  • Lahiri S., Anobile C. J., Stewart P., Ledger W. L. Changes in circulating concentrations of inhibins A and pro‐alpha C during first trimester medical termination of pregnancy. Hum Reprod 2003; 18: 744–8
  • Vaisanen‐Tommiska M., Nuutila M., Ylikorkala O. Cervical nitric oxide release in women postterm. Obstet Gynecol 2004; 103: 657–62
  • Sennstrom M. K., Brauner A., Lu Y., Granstrom L. M., Malmstrom A. L., Ekman G. E. Interleukin‐8 is a mediator of the final cervical ripening in humans. Eur J Obstet Gynecol Reprod Biol 1997; 74: 89–92
  • Sennstrom M. B., Brauner A., Bystrom B., Malmstrom A., Ekman G. Matrix metalloproteinase‐8 correlates with the cervical ripening process in humans. Acta Obstet Gynecol Scand 2003; 82: 904–11
  • Stygar D., Wang H., Vladic Y. S., Ekman G., Eriksson H., Sahlin L. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod 2002; 67: 889–94
  • Stjernholm‐Vladic Y., Stygar D., Mansson C., Masironi B., Akerberg S., Wang H., et al. Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol 2004; 2: 74
  • Kelly R. W. Inflammatory mediators and cervical ripening. J Reprod Immunol 2002; 57: 217–24
  • Osman I., Young A., Ledingham M. A., Thomson A. J., Jordan F., Greer I. A., et al. Leukocyte density and pro‐inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 2003; 9: 41–5
  • Yoshida M., Sagawa N., Itoh H., Yura S., Takemura M., Wada Y., et al. Prostaglandin F(2alpha), cytokines and cyclic mechanical stretch augment matrix metalloproteinase‐1 secretion from cultured human uterine cervical fibroblast cells. Mol Hum Reprod 2002; 8: 681–7
  • Olesen A. W., Basso O., Olsen J. Risk of recurrence of prolonged pregnancy. BMJ 2003; 326: 476
  • Kistka Z. A., Palomar L., Boslaugh S. E., DeBaun M. R., DeFranco E. A., Muglia L. J. Risk for postterm delivery after previous postterm delivery. Am J Obstet Gynecol 2007; 196: 241.e1–e6
  • Laursen M., Bille C., Olesen A. W., Hjelmborg J., Skytthe A., Christensen K. Genetic influence on prolonged gestation: a population‐based Danish twin study. Am J Obstet Gynecol 2004; 190: 489–94
  • Bullarbo M., Orrskog M. E., Andersch B., Granstrom L., Norstrom A., Ekerhovd E. Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. Am J Obstet Gynecol 2007; 196: 50.e1–e5
  • Dong Y. L., Gangula P. R., Fang L., Yallampalli C. Nitric oxide reverses prostaglandin‐induced inhibition in ovarian progesterone secretion in rats. Hum Reprod 1999; 14: 27–32
  • Ledingham M. A., Denison F. C., Kelly R. W., Young A., Norman J. E. Nitric oxide donors stimulate prostaglandin F(2alpha) and inhibit thromboxane B(2) production in the human cervix during the first trimester of pregnancy. Mol Hum Reprod 1999; 5: 973–82
  • Hausman N., Beharry K. D. B. S., Nishihara K. C. B. A., Akmal Y. B. S., Asrat T. Effect of the antenatal administration of celecoxib during the second and third trimesters of pregnancy on prostaglandin, cytokine, and nitric oxide levels in rabbits. Am J Obstet Gynecol 2003; 189: 1737–43
  • Gookin J. L., Duckett L. L., Armstrong M. U., Stauffer S. H., Finnegan C. P., Murtaugh M. P., et al. Nitric oxide synthase stimulates prostaglandin synthesis and barrier function in C. parvum‐infected porcine ileum. Am J Physiol Gastrointest Liver Physiol 2004; 287: G571–81
  • Timoshenko A. V., Lala P. K., Chakraborty C. PGE2‐mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors. Int J Cancer 2004; 108: 384–9
  • Goharkhay N., Wing D. A., Pan V., McCausland V., Hanna M., Naidu Y. M., et al. The expression of EP3‐6 and inducible nitric oxide synthase messenger RNA are correlated in pregnant and misoprostol‐treated but not in nongravid or menopausal myometrium. Am J Obstet Gynecol 2002; 186: 1202–6
  • Ogando D., Farina M., Ribeiro M. L., Perez Martinez S., Cella M., Rettori V., et al. Steroid hormones augment nitric oxide synthase activity and expression in rat uterus. Reprod Fertil Dev 2003; 15: 269–74
  • Vaisanen‐Tommiska M., Mikkola T. S., Ylikorkala O. Misoprostol induces cervical nitric oxide release in pregnant, but not in nonpregnant, women. Am J Obstet Gynecol 2005; 193: 790–6
  • Ekerhovd E., Enskog A., Caidahl K., Klintland N., Nilsson L., Brannstrom M., et al. Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome. Hum Reprod 2001; 16: 1334–9
  • Gruber C. J., Huber J. C. The role of dydrogesterone in recurrent (habitual) abortion. J Steroid Biochem Mol Biol 2005; 97: 426–30
  • Stjernholm‐Vladic Y., Wang H., Stygar D., Ekman G., Sahlin L. Differential regulation of the progesterone receptor A and B in the human uterine cervix at parturition. Gynecol Endocrinol 2004; 18: 41–6
  • Alderton W. K., Cooper C. E., Knowles R. G. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593–615
  • Denison F. C., Riley S. C., Elliott C. L., Kelly R. W., Calder A. A., Critchley H. O. The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix. Mol Hum Reprod 2000; 6: 541–8
  • Hapangama D. K., Critchley H. O., Henderson T. A., Baird D. T. Mifepristone‐induced vaginal bleeding is associated with increased immunostaining for cyclooxygenase‐2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium. J Clin Endocrinol Metab 2002; 87: 5229–34
  • Chwalisz K., Garfield R. E. Regulation of the uterus and cervix during pregnancy and labor. Role of progesterone and nitric oxide. Ann NY Acad Sci 1997; 828: 238–53
  • Chwalisz K., Winterhager E., Thienel T., Garfield R. E. Synergistic role of nitric oxide and progesterone during the establishment of pregnancy in the rat. Hum Reprod 1999; 14: 542–52
  • Facchinetti F., Paganelli S., Comitini G., Dante G., Volpe A. Cervical length changes during preterm cervical ripening: effects of 17‐alpha‐hydroxyprogesterone caproate. Am J Obstet Gynecol 2007; 196: 453.e1–4
  • da Fonseca E. B., Bittar R. E., Carvalho M. H., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo‐controlled double‐blind study. Am J Obstet Gynecol 2003; 188: 419–24
  • Greene M. F. Progesterone and preterm delivery‐‐deja vu all over again. N Engl J Med 2003; 348: 2453–5
  • Schindler A. E. Role of progestogens for the prevention of premature birth. J Steroid Biochem Mol Biol 2005; 97: 435–8
  • Di Renzo G. C., Mattei A., Gojnic M., Gerli S. Progesterone and pregnancy. Curr Opin Obstet Gynecol 2005; 17: 598–600
  • Shi L., Shi S. Q., Saade G. R., Chwalisz K., Garfield R. E. Studies of cervical ripening in pregnant rats: effects of various treatments. Mol Hum Reprod 2000; 6: 382–9
  • Thomson A. J., Lunan C. B., Ledingham M., Howat R. C., Cameron I. T., Greer I. A., et al. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first‐trimester termination of pregnancy. Lancet 1998; 352: 1093–6
  • Nicoll A. E., Mackenzie F., Greer I. A., Norman J. E. Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. Am J Obstet Gynecol 2001; 184: 958–64
  • Ekerhovd E., Bullarbo M., Andersch B., Norstrom A. Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: a randomized controlled study. Am J Obstet Gynecol 2003; 189: 1692–7
  • Li C. F., Chan C. W., Ho P. C. A comparison of isosorbide mononitrate and misoprostol cervical ripening before suction evacuation. Obstet Gynecol 2003; 102: 583–8
  • Li C. F., Chan C. W., Ho P. C. A study of the efficacy of cervical ripening with nitric oxide donor versus placebo for cervical priming before second‐trimester termination of pregnancy. Contraception 2003; 68: 269–72
  • Eppel W., Facchinetti F., Schleussner E., Piccinini F., Pizzi C., Gruber D. M., et al. Second trimester abortion using isosorbide mononitrate in addition to gemeprost compared with gemeprost alone: a double‐blind randomized, placebo‐controlled multicenter trial. Am J Obstet Gynecol 2005; 192: 856–61
  • David M., Chen F. C. Comparison of isosorbide mononitrate (Mono Mack) and misoprostol (Cytotec) for cervical ripening in the first trimester missed abortion. Arch Gynecol Obstet 2005; 273: 144–5
  • Wolfler M. M., Facchinetti F., Venturini P., Huber A., Helmer H., Husslein P., et al. Induction of labor at term using isosorbide mononitrate simultaneously with dinoprostone compared to dinoprostone treatment alone: A randomized, controlled trial. Am J Obstet Gynecol 2006; 195: 1617–22
  • Osman I., MacKenzie F., Norrie J., Murray H. M., Greer I. A., Norman J. E. The ‘PRIM’ study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. Am J Obstet Gynecol 2006; 194: 1012–21
  • Facchinetti F., Piccinini F., Volpe A. Chemical ripening of the cervix with intracervical application of sodium nitroprusside: a randomized controlled trial. Hum Reprod 2000; 15: 2224–7
  • Chan C. C., Tang O. S., Ng E. H., Li C. F., Ho P. C. Intracervical sodium nitroprusside versus vaginal misoprostol in first trimester surgical termination of pregnancy: a randomized double‐blinded controlled trial. Hum Reprod 2005; 20: 829–33
  • Chanrachakul B., Herabutya Y., Punyavachira P. Randomized comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstet Gynecol 2000; 96: 549–53
  • Sharma Y., Kumar S., Mittal S., Misra R., Dadhwal V. Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E gel for preinduction cervical ripening in term pregnancy. J Obstet Gynaecol Res 2005; 31: 210–5
  • Nunes F. P., Campos A. P., Pedroso S. R., Leite C. F., Avillez T. P., Rodrigues R. D., et al. Intravaginal glyceryl trinitrate and dinoprostone for cervical ripening and induction of labor. Am J Obstet Gynecol 2006; 194: 1022–6
  • Arteaga‐Troncoso G., Villegas‐Alvarado A., Belmont‐Gomez A., Martinez‐Herrera F. J., Villagrana‐Zesati R., Guerra‐Infante F. Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception. BJOG 2005; 112: 1615–9
  • de Pace V., Chiossi G., Facchinetti F. Clinical use of nitric oxide donors and L‐arginine in obstetrics. J Matern Fetal Neonatal Med 2007; 20: 569–79
  • Piccinini F., Fano R. A., Volpe A., Facchinetti F. Ripening of the cervix with sodium nitroprusside in nonpregnant women. J Soc Gynecol Investig 2003; 10: 438–42
  • Bullarbo M., Norstrom A., Andersch B., Ekerhovd E. Isosorbide mononitrate induces increased cervical expression of cyclooxygenase‐2, but not of cyclooxygenase‐1, at term. Eur J Obstet Gynecol Reprod Biol 2007; 130: 160–4
  • Cacciatore B., Halmesmaki E., Kaaja R., Teramo K., Ylikorkala O. Effects of transdermal nitroglycerin on impedance to flow in the uterine, umbilical, and fetal middle cerebral arteries in pregnancies complicated by preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 1998; 179: 140–5
  • Bates C. D., Nicoll A. E., Mullen A. B., Mackenzie F., Thomson A. J., Norman J. E. Serum profile of isosorbide mononitrate after vaginal administration in the third trimester. BJOG 2003; 110: 64–7
  • Kahler C., Schleussner E., Moller A., Seewald H. J. Nitric oxide donors: effects on fetoplacental blood flow. Eur J Obstet Gynecol Reprod Biol 2004; 115: 10–4
  • Radulovic N., Norström A., Ekerhovd E. Outpatient cervical ripening before first‐trimester surgical abortion: a comparison between Misoprostol and isosorbide mononitrate. Acta Obstet Gynecol Scand 2007; 86: 344–8
  • Ledingham M. A., Thomson A. J., Lunan C. B., Greer I. A., Norman J. E. A comparison of isosorbide mononitrate, misoprostol and combination therapy for first trimester pre‐operative cervical ripening: a randomised controlled trial. BJOG 2001; 108: 276–80
  • Maul H., Maner W. L., Saade G. R., Garfield R. E. The physiology of uterine contractions. Clin Perinatol 2003; 30: 665–76
  • Condous G., Okaro E., Bourne T. The conservative management of early pregnancy complications: a review of the literature. Ultrasound Obstet Gynecol 2003; 22: 420–30
  • Goepfert A. R., Goldenberg R. L., Mercer B., Iams J., Meis P., Moawad A., et al. The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. The National Institute of Child Health and Human Development Maternal‐Fetal Medicine Units Network. Am J Obstet Gynecol 2000; 183: 1480–3
  • Ascarelli M. H., Morrison J. C. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv 1997; 52: S1–12
  • Kekki M., Kurki T., Karkkainen T., Hiilesmaa V., Paavonen J., Rutanen E. M. Insulin‐like growth factor‐binding protein‐1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand 2001; 80: 546–51
  • Iams J. D. Prediction and early detection of preterm labor. Obstet Gynecol 2003; 101: 402–12
  • Honest H., Bachmann L. M., Coomarasamy A., Gupta J. K., Kleijnen J., Khan K. S. Accuracy of cervical transvaginal sonography in predicting preterm birth: a systematic review. Ultrasound Obstet Gynecol 2003; 22: 305–22

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.